To prove whether this holds true for other cell lines differing in p53 status, we analyzed the expression of TRAIL receptors in another two isogenic colon carcinoma cell lines RKO p53+/+ and p53−/− and in addition in a lung cancer cell line A549 with and without transient knockdown of p53. This evidence concerns the gene TP53 and lung cancer.